Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer (Q34563697)

3 August 2017

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer (English)

1 reference

3 August 2017

1 reference

9

Rosette Lidereau

0 references

Marc Buyse

1

Marc Buyse

0 references

Sherene Loi

Sherene Loi

2

0 references

Fátima Cardoso

Fatima Cardoso

19

0 references

Adrian Harris

Adrian Harris

11

0 references

Giuseppe Viale

4

Giuseppe Viale

1 reference

3 August 2017

8

Jonas Bergh

1 reference

3 August 2017

17

Emiel Rutgers

1 reference

3 August 2017

Laura van't Veer

3

1 reference

3 August 2017

Mauro Delorenzi

5

1 reference

3 August 2017

Annuska M Glas

6

1 reference

3 August 2017

Mahasti Saghatchian d'Assignies

7

1 reference

3 August 2017

Paul Ellis

10

1 reference

3 August 2017

Jan Bogaerts

12

1 reference

3 August 2017

Patrick Therasse

13

1 reference

3 August 2017

Arno Floore

14

1 reference

3 August 2017

Mohamed Amakrane

15

1 reference

3 August 2017

Fanny Piette

16

1 reference

3 August 2017

Christos Sotiriou

18

1 reference

3 August 2017

Martine J Piccart

20

1 reference

3 August 2017

TRANSBIG Consortium

21

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Journal of the National Cancer Institute

3 August 2017

1 reference

3 August 2017

98

1 reference

3 August 2017

1183-1192

1 reference

3 August 2017

17

1 reference

Predicting the clinical status of human breast cancer by using gene expression profiles

3 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Gene expression predictors of breast cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Gene expression profiles of primary breast tumors maintained in distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Confirmation of a prognostic index in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Revision of the American Joint Committee on Cancer staging system for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Microarray technology and its effect on breast cancer (re)classification and prediction of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Time-dependent ROC curves for censored survival data and a diagnostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Roadmap for developing and validating therapeutically relevant genomic classifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Outcome signature genes in breast cancer: is there a unique set?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ329

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ329

1 reference

3 August 2017

1 reference